Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
8.24
-0.28 (-3.29%)
At close: Feb 27, 2026, 4:00 PM EST
8.25
+0.01 (0.12%)
After-hours: Feb 27, 2026, 4:15 PM EST
Gyre Therapeutics Market Cap
Gyre Therapeutics has a market cap or net worth of $748.94 million as of February 27, 2026. Its market cap has decreased by -24.90% in one year.
Market Cap
748.94M
Enterprise Value
690.05M
1-Year Change
-24.90%
Ranking
Category
Stock Price
$8.24
Market Cap Chart
Since October 31, 2023, Gyre Therapeutics's market cap has increased from $515.41M to $748.94M, an increase of 45.31%. That is a compound annual growth rate of 17.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 748.94M | 16.71% |
| Dec 31, 2025 | 641.69M | -38.21% |
| Dec 31, 2024 | 1.04B | -47.22% |
| Dec 29, 2023 | 1.97B | 281.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KalVista Pharmaceuticals | 822.89M |
| Evommune | 819.63M |
| Prime Medicine | 817.92M |
| BridgeBio Oncology Therapeutics | 802.29M |
| Bright Minds Biosciences | 796.87M |
| AgomAb Therapeutics NV | 780.76M |
| Kura Oncology | 758.79M |
| MapLight Therapeutics | 753.69M |